Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779710/
https://www.ncbi.nlm.nih.gov/pubmed/29406534
http://dx.doi.org/10.2147/JPR.S160542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779710/
https://www.ncbi.nlm.nih.gov/pubmed/29406534
http://dx.doi.org/10.2147/JPR.S160542

Ejemplares similares